[The treatment characteristics of non-insulin-dependent diabetes mellitus].
Balabolkin
M I
MI
Kreminskaia
V M
VM
D001645:Biguanides / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000191:economics / Q000628:therapy*; D003927:Diet, Diabetic; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000172:deficiency; D013453:Sulfonylurea Compounds / Q000627:therapeutic use; D014481:United States
D001645:Biguanides; D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds